JM

Jennifer Martin

Sr. Account Executive-corporate Accounts And IDN Strategy at Diagnostic Cardiology at Baxter - U.S.

Jennifer Martin is a seasoned sales professional with extensive experience in the medical device sector, currently serving as Sr. Account Executive for Corporate Accounts and IDN Strategy at Bardy Diagnostics, Inc. since February 2018, specializing in innovative ECG monitoring solutions. Previously, Jennifer held the role of Territory Manager for GYN Surgical Services at Hologic, Inc., where successful sales of surgical devices were achieved, earning acknowledgment as a Total Quota Buster in 2017. Earlier career highlights include significant contributions as Territory Manager at Devicor Medical Products and Angiotech, the latter achieving President's Club status in 2009. Jennifer began their career at American Reprographics Corporation as Director of Facilities Management, where multiple sales awards were received. A Biology graduate from the University of Nevada, Reno, Jennifer combines academic knowledge with a proven track record in sales performance across various medical and printing sectors.

Location

Seattle, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Diagnostic Cardiology at Baxter - U.S.

1 followers

Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Itsunique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape.Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses.Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.